Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Fresenius SE & Co. KGaA | 3 | 0 | 0 | 0 | €31.88 | - | - |
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.84 | €20.00 | 6.157% |
| Gerresheimer AG | 4 | 0 | 0 | 0 | €94.55 | - | - |
| Hologic Inc. | 17 | 0 | 1 | 0 | €72.50 | €83.47 | 15.126% |
| Steris Corp. | 1 | 0 | 0 | 0 | €210.00 | - | - |
| Sartorius AG VZO | 5 | 0 | 2 | 0 | €243.80 | - | - |
| Astellas Pharma Inc. | 1 | 0 | 0 | 0 | €10.25 | - | - |
| Laboratory Corp. Of America (labcorp) | 12 | 0 | 1 | 0 | €197.00 | €237.94 | 20.782% |
| Idexx Laboratories Inc. | 13 | 0 | 0 | 0 | €432.60 | €550.70 | 27.301% |
| Sanofi S.A. ADR | 10 | 0 | 1 | 0 | €48.40 | €55.25 | 14.161% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.85 | €65.00 | -4.200% |
| Glaukos Corp | 1 | 0 | 0 | 0 | €109.00 | - | - |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €2.88 | €12.21 | 323.990% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €143.80 | €165.00 | 14.743% |
| Drägerwerk AG & Co. KGaA VZO | 4 | 0 | 1 | 0 | €48.45 | €60.00 | 23.839% |
| Veracyte Inc. | 1 | 0 | 0 | 0 | €22.00 | - | - |
| Stratec SE | 2 | 0 | 0 | 0 | €41.40 | - | - |
| Knight Therapeutics | 1 | 0 | 0 | 0 | €3.72 | €10.00 | 168.817% |
| Adverum Biotechnologies Inc. | 9 | 0 | 1 | 0 | €1.38 | €20.55 | 1388.986% |
| R1 RCM Inc. | 23 | 0 | 4 | 0 | €11.80 | €17.21 | 45.869% |
| iRhythm Technologies Inc | 13 | 0 | 1 | 0 | €87.50 | €121.75 | 39.148% |
| Pro-Dex Inc. | 12 | 0 | 0 | 0 | €17.20 | - | - |
| Rhythm Pharmaceuticals | 16 | 0 | 1 | 0 | €45.60 | €46.37 | 1.689% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Catalyst Pharmaceutical Partners Inc | 13 | 0 | 0 | 0 | €16.20 | €24.44 | 50.882% |